William Edward Hinman, PA-C | |
721 W 6th Avenue, Red Cloud, NE 68970 | |
(402) 746-5614 | |
(402) 746-5684 |
Full Name | William Edward Hinman |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 721 W 6th Avenue, Red Cloud, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770579088 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 84 (Nebraska) | Secondary |
207Q00000X | Family Medicine | 84 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
William Edward Hinman, PA-C 721 W 6th Avenue, Red Cloud, NE 68970 Ph: (402) 746-5614 | William Edward Hinman, PA-C 721 W 6th Avenue, Red Cloud, NE 68970 Ph: (402) 746-5614 |
News Archive
RxVantage, a healthcare technology company with an innovative cloud-based platform that enables physicians' practices to streamline and improve their relationships with pharmaceutical and other medical sales reps, today announced the release of the RxVantage iPhone application.
The investigators used machine learning to predict which patients might get worse and not respond positively to being turned onto their front in intensive care units (ICUs) - a technique known as proning that is commonly used in this setting to improve oxygenation of the lungs.
When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection more likely or vaccination less effective.
Men who use androgenic anabolic steroids—such as testosterone—may face a higher risk of early death and of experiencing more hospital admissions, according to a new Journal of Internal Medicine study.
A new class of antibody drugs may provide a powerful new tool for the treatment of eye diseases in children, but specialists need to be alert for the possibility of serious side effects, according to an editorial in the August Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus), published by Elsevier.
› Verified 9 days ago